Pediatric Oncology and Nursing

About Conference

Conference Series Ltd invites all participants from around the world to attend the "24th World Congress on Pediatric Oncology and Nursing", taking place on February 11-12, 2027, in Toronto, Canada. The conference will bring together leading pediatric oncologists, nurses, physicians, researchers, academics, healthcare professionals, students, and industry experts for an engaging scientific program featuring keynote presentations, plenary sessions, oral talks, poster presentations, workshops, interactive discussions, and exhibitions.

Pediatric Oncology 2027 will provide an international platform to explore the latest advances in pediatric cancer diagnosis, treatment, nursing care, research, and patient support. The congress will focus on emerging therapeutic approaches, precision medicine, immunotherapy, targeted therapies, pediatric cancer biology, survivorship, supportive care, and innovations in pediatric oncology nursing. It will also provide opportunities for participants to exchange knowledge, discuss challenges, establish professional collaborations, and share innovative research and clinical experiences.

Conference Series Ltd organizes a broad range of global scientific events, bringing together researchers, healthcare professionals, academic institutions, scientific societies, pharmaceutical companies, and industry leaders from across the world. These events provide valuable opportunities for scientific networking, knowledge exchange, collaboration, and professional development.

Why to Attend?

The 24th World Congress on Pediatric Oncology and Nursing provides an excellent opportunity for professionals and students to:

• Discover the latest developments in pediatric oncology diagnosis and treatment.
• Learn about emerging approaches including immunotherapy, targeted therapy, precision medicine, and personalized cancer care.
• Explore advances in pediatric oncology nursing and supportive patient care.
• Hear from internationally recognized experts and researchers.
• Present research findings through oral and poster presentations.
• Exchange ideas, experiences, and best practices with peers from around the world.
• Develop professional and research collaborations.
• Explore innovative technologies, products, and services presented by participating organizations.
• Gain insights into current challenges and future directions in pediatric cancer care.
• Expand professional networks and create opportunities for career development.

Sessions/Tracks

Track 1: Pediatric Oncology
Pediatric oncology focuses on the diagnosis, treatment, and comprehensive management of cancers affecting infants, children, and adolescents. This track will explore recent advances in childhood cancer research, innovative treatment approaches, pediatric hematologic malignancies, solid tumors, cancer biology, precision medicine, immunotherapy, targeted therapies, survivorship, and multidisciplinary pediatric cancer care.

Track 2: Clinical Pediatrics
Clinical pediatrics encompasses the prevention, diagnosis, and management of diseases and health conditions affecting children from infancy through adolescence. Sessions will address child growth and development, infectious diseases, nutrition, pediatric disorders, preventive healthcare, developmental medicine, and evidence-based approaches to improving the health and wellbeing of children.

Track 3: Pediatric Hematology-Oncology
Pediatric hematology-oncology addresses blood disorders and cancers in children, including leukemia, lymphoma, anemia, bleeding and clotting disorders, and other hematologic conditions. This track will highlight advances in diagnosis, molecular characterization, treatment, transfusion medicine, stem cell transplantation, supportive care, and emerging therapeutic strategies.

Track 4: Pediatric Leukemia
Leukemia is among the most common cancers diagnosed in children. This track will cover acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), juvenile myelomonocytic leukemia (JMML), and other pediatric leukemias. Topics will include molecular diagnosis, risk stratification, chemotherapy, targeted therapy, immunotherapy, hematopoietic stem cell transplantation, minimal residual disease, relapse management, and survivorship.

Track 5: Pediatric Brain
Pediatric brain and central nervous system tumors require highly specialized multidisciplinary care. This track will discuss brain tumor biology, molecular classification, neuroimaging, neurosurgery, radiation therapy, chemotherapy, targeted treatments, immunotherapy, proton therapy, neurorehabilitation, and strategies for reducing treatment-related neurological and developmental complications.

Track 6: Pediatric Neuro-Oncology
Pediatric neuro-oncology focuses on tumors affecting the brain, spinal cord, and peripheral nervous system in children. Presentations will address tumor genetics, molecular profiling, advanced imaging, surgical techniques, radiation approaches, novel systemic therapies, clinical trials, neurological supportive care, and long-term outcomes for children with central nervous system malignancies.

Track 7: Pediatric Solid Tumors
This track will focus on common and rare solid tumors of childhood, including neuroblastoma, Wilms tumor, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, hepatoblastoma, germ cell tumors, and other pediatric malignancies. Discussions will include tumor biology, early diagnosis, staging, multimodal treatment, surgical oncology, chemotherapy, radiation therapy, targeted therapies, and emerging treatments.

Track 8: Pediatric Cancer Genetics
Genetic and genomic research is transforming the understanding of childhood cancers. This track will explore hereditary cancer predisposition, somatic and germline mutations, tumor sequencing, epigenetics, molecular classification, genomic biomarkers, precision oncology, pharmacogenomics, and the application of genomic information to individualized pediatric cancer treatment.

Track 9: Pediatric Oncology Diagnosis
Accurate and timely diagnosis is essential for effective pediatric cancer management. This track will cover laboratory investigations, pathology, molecular diagnostics, radiography, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), nuclear medicine, image-guided procedures, and emerging technologies for detecting and monitoring childhood cancers.

Track 10: Pediatric Oncology Treatment
Treatment of childhood cancer often requires a combination of surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplantation. This track will highlight advances in multimodal treatment, precision medicine, novel drugs, cellular therapies, antibody-based treatments, treatment response assessment, management of relapse, and strategies to minimize treatment-related toxicity.

Track 11: Pediatric Immunotherapy
Immunotherapy and targeted therapies are rapidly changing the pediatric oncology landscape. This track will explore monoclonal antibodies, immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, antibody-drug conjugates, molecularly targeted agents, cellular therapies, biomarkers, resistance mechanisms, and the development of personalized treatment strategies for childhood cancers.

Track 12: Pediatric Oncology Clinical Trials
Clinical trials are essential for evaluating new treatments and improving outcomes for children with cancer. Sessions will focus on early-phase and multicenter trials, novel therapeutics, trial design, patient recruitment, biomarkers, precision medicine trials, regulatory considerations, clinical trial ethics, treatment response, and the translation of research discoveries into clinical practice.

Track 13: Pediatric Cancer Nursing
Pediatric oncology nurses play a central role in the multidisciplinary care of children with cancer and their families. This track will address chemotherapy administration, symptom management, infection prevention, pain management, patient education, psychosocial support, care coordination, family-centered care, survivorship, and nursing innovations in pediatric oncology.

Track 14: Pediatric Nursing
Pediatric nursing provides specialized healthcare to infants, children, and adolescents across hospital and community settings. Topics will include pediatric assessment, medication administration, developmental care, infection control, chronic disease management, health education, family-centered nursing, communication with children, and evidence-based pediatric nursing practice.

Track 15: Neonatal and Perinatal Nursing
Neonatal and perinatal nursing focuses on the care of newborns and mothers before, during, and after childbirth. This track will explore neonatal intensive care, premature infants, neonatal resuscitation, congenital conditions, neonatal infections, developmental care, maternal-newborn health, perinatal complications, and family-centered approaches to neonatal nursing.

Market Analysis

The 24th World Congress on Pediatric Oncology and Nursing, to be held on February 11–12, 2027, in Toronto, Canada, brings together pediatric oncologists, pediatricians, oncology nurses, researchers, academics, healthcare professionals, pharmaceutical and biotechnology experts, and industry leaders to discuss advances in childhood cancer care. Pediatric oncology remains an important global healthcare field, with the World Health Organization estimating that approximately 400,000 children and adolescents aged 0–19 develop cancer each year. While survival exceeds 80% in many high-income countries, outcomes remain considerably lower in low- and middle-income countries, highlighting the continuing need for improved diagnosis, treatment, access to medicines, nursing care, clinical research, and international collaboration.

The pediatric oncology market is being driven by advances in precision medicine, genomic testing, molecular diagnostics, immunotherapy, targeted therapies, cellular therapies, pediatric drug development, advanced imaging, radiation technology, and clinical trials. Increasing numbers of childhood cancer survivors are also creating greater demand for survivorship programs, rehabilitation, psychosocial support, long-term monitoring, and comprehensive nursing care. WHO continues to emphasize the need to improve access to quality-assured childhood cancer medicines and age-appropriate formulations, while global initiatives aim to increase childhood cancer survival and reduce disparities between countries. These developments create opportunities for pharmaceutical companies, biotechnology firms, diagnostic providers, medical-device manufacturers, clinical research organizations, healthcare technology companies, hospitals, universities, and research institutions to participate in the pediatric oncology ecosystem.

The 24th World Congress on Pediatric Oncology and Nursing provides a specialized international platform for knowledge exchange, research presentation, professional networking, and industry collaboration. The congress will address areas including pediatric oncology, pediatric hematology-oncology, leukemia, pediatric brain tumors, neuro-oncology, cancer genetics and genomics, cancer diagnosis and treatment, immunotherapy, clinical trials, pediatric oncology nursing, palliative care, intensive care, survivorship, rehabilitation, nutrition, and comprehensive cancer care. With Toronto's strong healthcare, academic, and research environment, the conference offers an opportunity to connect the global pediatric oncology and nursing community and encourage collaboration toward improved childhood cancer outcomes, innovative treatments, and higher-quality patient-centered care.